If you liked this article you might like

Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta

Biotech Movers: Akebia Shares Down After Pricing Stock Offering

Biotech Movers: Akebia, Editas, Novavax

Akebia Secures Exclusive Access to U.S. Dialysis Patients With Vifor-Fresenius Pact

Akebia Surges but is Still Undervalued, Making Takeover a Potential Remedy